Article

ThinOptX lens placed in first U.S. patients

Santa Monica, CA-The first three U.S. cataract patients to receive the ThinOptX lens have achieved 20/20 uncorrected visual acuity 4 days after implantation.

Santa Monica, CA-The first three U.S. cataract patients to receive the ThinOptX lens have achieved 20/20 uncorrected visual acuity 4 days after implantation.

The ultra-thin lens, which has been used in Europe for about 18 months, was inserted into one eye in each of three patients by Kenneth J. Hoffer, MD, at his St. Mary's Eye Center here.

Dr. Hoffer said the implantations went "beautifully" through 2.4-mm incisions. He is a clinical professor of ophthalmology at the University of California at Los Angeles' Jules Stein Eye Institute and serves on the company's board of directors.

The lens unrolls when it reaches the warm aqueous, he said, and the self-sealing incisions healed quickly. The patients will be followed at regular intervals.

"I'm very happy. I'm ecstatic; and it went successfully," he said.

Dr. Hoffer said future trials will include about 20 investigators implanting 15 to 20 lenses each, with smaller incisions. In Europe, some 9,000 ThinOptX lenses have been implanted, many with incisions of 1.5 mm or smaller, he said.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
© 2025 MJH Life Sciences

All rights reserved.